# Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone

> **NCT03370705** · PHASE3 · UNKNOWN · sponsor: **Alfa Wassermann Tunisia** · enrollment: 156 (estimated)

## Conditions studied

- Peripheral Arterial Obstructive Disease

## Interventions

- **DRUG:** Sulodexide
- **DRUG:** Statin
- **DRUG:** Antiplatelet Agents
- **DRUG:** ACE inhibitor

## Key facts

- **NCT ID:** NCT03370705
- **Lead sponsor:** Alfa Wassermann Tunisia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-31
- **Primary completion:** 2019-12-30
- **Final completion:** 2020-03-30
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2019-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03370705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03370705, "Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03370705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*